DJ Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ shed 1.07% to $541.69 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.25% to 7,711.76 and Dow Jones Industrial Average falling 0.02% to 53,559.99.
Vertex Pharmaceuticals Inc. closed 2.52% short of its 52-week high of $555.69, which the company achieved on August 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ fell 1.03% to $255.48, Krystal Biotech Inc. (KRYS) fell 1.68% to $351.46, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 6.06% to $15.19.
Trading volume (886,544) remained 689,441 below its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.